Third Rock Ventures Iv, L.p. - Net Worth and Insider Trading
Third Rock Ventures Iv, L.p. Net Worth
The estimated net worth of Third Rock Ventures Iv, L.p. is at least $156 Million dollars as of 2024-05-11. Third Rock Ventures Iv, L.p. is the 10% Owner of Tango Therapeutics Inc and owns about 19,201,475 shares of Tango Therapeutics Inc (TNGX) stock worth over $136 Million. Third Rock Ventures Iv, L.p. is the 10% Owner of Fulcrum Therapeutics Inc and owns about 2,343,154 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $18 Million. Third Rock Ventures Iv, L.p. is also the 10% Owner of Magenta Therapeutics Inc and owns about 3,058,204 shares of Magenta Therapeutics Inc (MGTA) stock worth over $2 Million. Details can be seen in Third Rock Ventures Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Third Rock Ventures Iv, L.p. has not made any transactions after 2024-02-20 and currently still holds the listed stock(s).
Transaction Summary of Third Rock Ventures Iv, L.p.
Third Rock Ventures Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Third Rock Ventures Iv, L.p. owns 6 companies in total, including Relay Therapeutics Inc (RLAY) , Pliant Therapeutics Inc (PLRX) , and Revolution Medicines Inc (RVMD) among others .
Click here to see the complete history of Third Rock Ventures Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of Third Rock Ventures Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RLAY | Relay Therapeutics Inc | 2020-07-15 | 10 percent owner |
| PLRX | Pliant Therapeutics Inc | 2020-06-02 | 10 percent owner |
| RVMD | Revolution Medicines Inc | 2020-02-12 | 10 percent owner |
 | | 2019-07-22 | 10 percent owner |
| | 2023-02-08 | 10 percent owner |
| | 2024-02-20 | 10 percent owner |
Third Rock Ventures Iv, L.p. Latest Holdings Summary
Third Rock Ventures Iv, L.p. currently owns a total of 3 stocks. Among these stocks, Third Rock Ventures Iv, L.p. owns 19,201,475 shares of Tango Therapeutics Inc (TNGX) as of February 20, 2024, with a value of $136 Million and a weighting of 87.41%. Third Rock Ventures Iv, L.p. owns 2,343,154 shares of Fulcrum Therapeutics Inc (FULC) as of July 22, 2019, with a value of $18 Million and a weighting of 11.22%. Third Rock Ventures Iv, L.p. also owns 3,058,204 shares of Magenta Therapeutics Inc (MGTA) as of February 8, 2023, with a value of $2 Million and a weighting of 1.37%.
Latest Holdings of Third Rock Ventures Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TNGX | Tango Therapeutics Inc | 2024-02-20 | 19,201,475 | 7.11 | 136,426,480 |
| FULC | Fulcrum Therapeutics Inc | 2019-07-22 | 2,343,154 | 7.47 | 17,503,360 |
| MGTA | Magenta Therapeutics Inc | 2023-02-08 | 3,058,204 | 0.70 | 2,139,520 |
Holding Weightings of Third Rock Ventures Iv, L.p.
Third Rock Ventures Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Third Rock Ventures Iv, L.p. has made a total of 1 transactions in Tango Therapeutics Inc (TNGX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Tango Therapeutics Inc is the sale of 162,500 shares on February 20, 2024, which brought Third Rock Ventures Iv, L.p. around $2 Million.
According to the SEC Form 4 filings, Third Rock Ventures Iv, L.p. has made a total of 1 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fulcrum Therapeutics Inc is the acquisition of 81,250 shares on July 22, 2019, which cost Third Rock Ventures Iv, L.p. around $1 Million.
According to the SEC Form 4 filings, Third Rock Ventures Iv, L.p. has made a total of 1 transactions in Magenta Therapeutics Inc (MGTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Magenta Therapeutics Inc is the sale of 3,700,000 shares on February 8, 2023, which brought Third Rock Ventures Iv, L.p. around $3 Million.
Insider Trading History of Third Rock Ventures Iv, L.p.
- 1
Third Rock Ventures Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Third Rock Ventures Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Third Rock Ventures Iv, L.p. is -59.61%. GuruFocus also compares Third Rock Ventures Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Third Rock Ventures Iv, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Third Rock Ventures Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of Third Rock Ventures Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.3 | | | | | |
| Relative Return to S&P 500(%) | -7.22 | | | | | |
Third Rock Ventures Iv, L.p. Ownership Network
Third Rock Ventures Iv, L.p. Owned Company Details
What does Relay Therapeutics Inc do?
Who are the key executives at Relay Therapeutics Inc?
Third Rock Ventures Iv, L.p. is the 10 percent owner of Relay Therapeutics Inc. Other key executives at Relay Therapeutics Inc include See remarks Peter Rahmer , Vice President & Finance Thomas Catinazzo , and See Remarks Donald A Bergstrom .
Relay Therapeutics Inc (RLAY) Insider Trades Summary
Over the past 18 months, Third Rock Ventures Iv, L.p. made no insider transaction in Relay Therapeutics Inc (RLAY). Other recent insider transactions involving Relay Therapeutics Inc (RLAY) include a net sale of 20,412 shares made by Brian Adams , a net sale of 12,851 shares made by Thomas Catinazzo , and a net sale of 19,262 shares made by Donald A Bergstrom .
In summary, during the past 3 months, insiders sold 9,108 shares of Relay Therapeutics Inc (RLAY) in total and bought 0 shares, with a net sale of 9,108 shares. During the past 18 months, 188,690 shares of Relay Therapeutics Inc (RLAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 188,690 shares.
Relay Therapeutics Inc (RLAY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Relay Therapeutics Inc Insider Transactions
Third Rock Ventures Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Third Rock Ventures Iv, L.p.. You might contact Third Rock Ventures Iv, L.p. via mailing address: 29 Newbury Street, 3rd Floor, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
